CBD · Compliance
CBD Novel-Food Status in Europe: What Importers Must Verify
Updated 18 Aug 2026 · 6 min read · For verified B2B resellers
CBD sits in one of the most actively enforced corners of EU consumer regulation. The single most common mistake importers make is assuming a product that is legal in one country is legal everywhere. It usually is not. This guide frames the questions you must answer before a CBD SKU touches your warehouse.
1. The novel-food starting point
Under the EU Novel Food Regulation (2015/2283), food containing cannabinoids derived from Cannabis sativa is generally treated as a novel food — meaning it requires authorisation before it can be legally marketed as a food or food supplement. Extracts intended for ingestion fall squarely in scope.
2. Topical vs ingestible is the line that matters
A topical balm applied to the skin and an ingestible dropper oil are regulated very differently. We supply both formats, but the compliance question is not ours to answer: the reseller must confirm the status of the specific format and concentration in each destination market.
3. Authorisation status changes
The list of authorised novel foods and the transitional measures around CBD have shifted repeatedly. Treat any "CBD is legal in the EU" statement as incomplete — what matters is the authorised status of the exact extract, the claimed use, and the country of sale.
4. Per-country nuance
Even where a novel-food authorisation exists at EU level, national controls on THC thresholds, narcotics scheduling, and retail permissions differ. Build a country-by-country check rather than a single blanket assumption.
5. Importer verification checklist
- Confirm whether the exact format (topical / ingestible) requires novel-food authorisation in each target country
- Verify THC threshold rules and certificates of analysis (COA) per batch
- Obtain supplier source documentation and keep it in your compliance file
- Confirm labelling and health-claim restrictions with local counsel